Publikationen, an denen er mitarbeitet Rafael Marcos Gragera (104)

2024

  1. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

2023

  1. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage

    Frontiers in Oncology, Vol. 13

  2. Childhood and Adolescent Central Nervous System Tumours in Spain: Incidence and Survival over 20 Years: A Historical Baseline for Current Assessment

    Cancers, Vol. 15, Núm. 24

  3. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes

    Frontiers in Oncology, Vol. 13

  4. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 593-606

  5. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592

  6. Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983–2018

    Frontiers in Oncology, Vol. 13

2022

  1. Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations

    Cancers, Vol. 14, Núm. 18

  2. Bayesian variable selection and survival modeling: assessing the Most important comorbidities that impact lung and colorectal cancer survival in Spain

    BMC Medical Research Methodology, Vol. 22, Núm. 1

  3. Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN)

    Cancers, Vol. 14, Núm. 10

  4. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

    Frontiers in Oncology, Vol. 12

  5. Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN)

    Frontiers in Oncology, Vol. 12

  6. Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registries

    Scientific Reports, Vol. 12, Núm. 1

  7. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

    The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 409-431

2021

  1. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

    Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645

  2. Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet)

    Cancer Epidemiology, Vol. 70

  3. Study protocol on Socioeconomic and Geographic Inequalities in Cancer Incidence, Mortality and Survival in Spain: Multilevel Population-Base Study: DESOCANES study

    Gaceta Sanitaria, Vol. 35, Núm. 2, pp. 199-203

  4. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)

    Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776

  5. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study

    BMC Cancer, Vol. 21, Núm. 1

  6. Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study

    Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1429-1439